This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: University of California. Active years: 2003-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Los Angeles, CA (US) (2012)
- Pacific Palisades, CA (US) (2003 - 2017)
Company Filing History:
Years Active: 2003-2017
Title: Innovations of Johannes Czernin
Introduction
Johannes Czernin is a notable inventor based in Pacific Palisades, CA (US). He has made significant contributions to the field of nanoparticle technology and medicinal chemistry. With a total of 4 patents, his work has implications in both scientific research and clinical applications.
Latest Patents
Czernin's latest patents include a supramolecular approach for the preparation of size-controllable nanoparticles. This innovative method utilizes three different molecular building blocks to create nanoparticles with precise sizes. Another significant invention is related to deoxycytidine kinase binding compounds. These compounds are designed to bind to deoxycytidine kinase (dCK) and are useful in treating diseases where dCK activity is implicated, such as cancer and immune disorders. Additionally, these compounds have applications in clinical methodologies, including positron emission tomography (PET) imaging.
Career Highlights
Johannes Czernin is affiliated with the University of California, where he conducts his research and development. His work has garnered attention for its potential to advance therapeutic strategies and improve diagnostic techniques.
Collaborations
Czernin has collaborated with esteemed colleagues, including Caius G Radu and Nagichettiar Satyamurthy. Their combined expertise enhances the impact of their research endeavors.
Conclusion
Johannes Czernin's innovative contributions to nanoparticle technology and medicinal chemistry highlight his role as a leading inventor in his field. His patents reflect a commitment to advancing science and improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile